Researchers at University of Pennsylvania and Regeneron are studying delivery of synthetic antibodies directly to the nose to prevent Covid-19 infections. . . . → Read More: Univ, Industry Labs Study Inhaled Covid-19 Antibodies
|
|||||
|
       
  |
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies 
A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches 
A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway 
News of those trials fueled healthy share price rises for the biotechnology companies developing the vaccines, shown in this weekend’s infographic. . . . → Read More: Infographic – Vaccines Boost Biotech Shares 
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal 
Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival. . . . → Read More: Nanoscale Particles Deliver Crispr Cancer Treatments 
A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding. . . . → Read More: Cancer Immune System Therapy Start-Up Raises $53M 
The Food and Drug Administration gave an emergency authorization for a self-collected Covid-19 diagnostic test, the first such test for home use. . . . → Read More: FDA Grants Emergency Clearance for Home Covid-19 Test 
Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo. . . . → Read More: ALS Stem Cell Therapy Fails to Meet Trial Objective |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
